Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of life-Reference-Cited by-同舟云学术

Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of life

Published:2009-05-07 Issue:10 Volume:24 Page:1468-1474
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Honig Holger,Antonini Angelo,Martinez-Martin Pablo,Forgacs Ian,Faye Guy C.,Fox Thomas,Fox Karen,Mancini Francesca,Canesi Margherita,Odin Per,Chaudhuri K. Ray

Funder

Boehringer-Ingelheim

Solvay

Novartis

GSK

UCB pharma

Brittannia Pharmaceuticals

Cephalon

GlaxoSmithKline

Orion Pharma

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.22596/fullpdf

Reference36 articles.

1. Problems with long-term levodopa therapy for Parkinson's disease;Marsden;Clin Neuropharmacol,1994

2. Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover;de la Fuente-Fernández;Ann Neurol,2001

3. Dopamine agonist therapy in early Parkinson's disease;Stowe;Cochrane Database Syst Rev,2008

4. Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in patients with Parkinson's disease;Nutt;Neurology,1994

5. Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial;Rascol;Lancet,2005

Cited by 230 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of the Dietary Intake of Vitamin B12, Folic Acid, and Vitamin D3 on Homocysteine Levels and the Health-Related Quality of Life of Levodopa-Treated Patients with Parkinson’s Disease—A Pilot Study in Romania;Diagnostics;2024-07-26

2. Subcutaneous Levodopa: A New Engine for the Vintage Molecule;Neurology and Therapy;2024-06-14

3. Bridging the gap between statistical significance and clinical relevance: A systematic review of minimum clinically important difference (MCID) thresholds of scales reported in movement disorders research;Heliyon;2024-03

4. Levodopa-carbidopa intestinal gel infusion in Parkinson's disease;International Review of Movement Disorders;2024

5. Levodopa‐Entacapone‐Carbidopa Intestinal Gel Treatment in Advanced Parkinson's Disease: A Single‐Center Study of 30 Patients;Movement Disorders Clinical Practice;2023-12-10